摘要
在过去的三十年里广泛的研究已经表明,代谢型谷氨酸(mGlu)受体在中枢神经系统(CNS)主要功能中有重要作用。很多的临床前研究提供的证据表明,代谢型谷氨酸受体的靶向药物能有效减轻动物模型中的症状发展和许多中枢神经系统疾病的进展。本综述总结了在病理生理学神经精神疾病(精神分裂症、抑郁症、焦虑症和认知障碍,疼痛的感知和上瘾)参与代谢型谷氨酸受体的当前知识,包括神经退行性疾病(老年痴呆症,阿尔茨海默氏病和帕金森病)和神经发育(脆性X综合症和自闭症谱系障碍)疾病。我们进一步强调治疗在这些疾病中代谢型谷氨酸受体的药理调节潜力,用这些化合物描述临床试验的结果和讨论转化困难的潜在来源。
关键词: 自闭症,脆性X综合症,精神障碍,代谢型谷氨酸受体,神经退行性疾病,疼痛。
图形摘要
Current Drug Targets
Title:Metabotropic Glutamate Receptors in Central Nervous System Diseases
Volume: 17 Issue: 5
Author(s): Anna V. Golubeva, Rachel D. Moloney, Richard M. O’Connor, Timothy G. Dinan and John F. Cryan
Affiliation:
关键词: 自闭症,脆性X综合症,精神障碍,代谢型谷氨酸受体,神经退行性疾病,疼痛。
摘要: Extensive research over the past thirty years has demonstrated a vital role for metabotropic glutamate (mGlu) receptors in the major functions of the central nervous system (CNS). A wealth of preclinical studies provide evidence that pharmacological targeting of mGlu receptors can effectively attenuate the development of symptoms and progression of many CNS disorders in animal models. In this review we summarize the current knowledge on the involvement of mGlu receptors in the pathophysiology of neuropsychiatric disorders (schizophrenia, depression, anxiety and cognitive disorders, pain perception and addiction), as well as neurodegenerative (Alzheimer’s, Huntington’s and Parkinson’s diseases) and neurodevelopmental (fragile X syndrome and autism spectrum disorders) diseases. We further emphasize the therapeutic potential of mGlu receptors’ pharmacological modulators in these diseases, describe the results of clinical trials with these compounds and discuss the potential sources of translational difficulties.
Export Options
About this article
Cite this article as:
Anna V. Golubeva, Rachel D. Moloney, Richard M. O’Connor, Timothy G. Dinan and John F. Cryan , Metabotropic Glutamate Receptors in Central Nervous System Diseases, Current Drug Targets 2016; 17 (5) . https://dx.doi.org/10.2174/1389450116666150316224011
DOI https://dx.doi.org/10.2174/1389450116666150316224011 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Identifying Endogenous Neural Stem Cells in the Adult Brain In Vitro and In Vivo: Novel Approaches
Current Pharmaceutical Design Monoclonal Antibodies in the Management of Solid Tumors
Current Topics in Medicinal Chemistry Molecular Imaging Aided Improvement in Drug Discovery and Development
Current Biotechnology The Transcription Factor ETS-1: Its Role in Tumour Development and Strategies for its Inhibition
Mini-Reviews in Medicinal Chemistry De Novo DNMTs and DNA Methylation: Novel Insights into Disease Pathogenesis and Therapy from Epigenomics
Current Pharmaceutical Design Quantitative Proteomics for Cancer Biomarker Discovery
Combinatorial Chemistry & High Throughput Screening Yttrium-90 – Current Status, Expected Availability and Applications of a High Beta Energy Emitter
Current Radiopharmaceuticals Radionuclide Liver Cancer Therapies: From Concept to Current Clinical Status
Anti-Cancer Agents in Medicinal Chemistry In vivo behavior and Safety of Lapatinib-Incorporated Lipid Nanoparticles
Current Pharmaceutical Biotechnology Cellomics as Integrative Omics for Cancer
Current Proteomics Targetin g Human Tel omerase by Antisens e Oligonucleotides and Ribozymes
Current Medicinal Chemistry - Anti-Cancer Agents Plasticity of Neuroendocrine-Immune Interactions During Ontogeny: Role of Perinatal Programming in Pathogenesis of Inflammation and Stress- Related Diseases in Adults
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Influence of Trishomocubanes on Sigma Receptor Binding of N-(1-Benzylpiperidin- 4-yl)-4-[123I]iodobenzamide In Vivo in the Rat Brain
Medicinal Chemistry Working Hypothesis: Elimination of Cancer Stem Cells in Solid Tumors by Immuno-Gene Therapy Using Cancer Vaccines and Created-Inhibitory RNA
Current Cancer Therapy Reviews Hemichannels in the Neurovascular Unit and White Matter Under Normal and Inflamed Conditions
CNS & Neurological Disorders - Drug Targets Application of Spray-drying and Electrospraying/Electospinning for Poorly Watersoluble Drugs: A Particle Engineering Approach
Current Pharmaceutical Design Resveratrol and Ischemic Preconditioning in the Brain
Current Medicinal Chemistry Current Approaches for Drug Delivery to Central Nervous System
Current Drug Delivery Induced pluripotent stem cell-derived mesenchymal stem cells: A leap toward personalized therapies.
Current Stem Cell Research & Therapy Targeting Angiogenic Pathways in Colorectal Cancer: Complexities, Challenges and Future Directions
Current Drug Targets